![Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies - The Lancet Diabetes & Endocrinology Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1b5e0dc9-6c0b-49ef-99f8-9d1edd76ded4/gr1.jpg)
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies - The Lancet Diabetes & Endocrinology
![Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus | Nature Reviews Endocrinology Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrendo.2017.173/MediaObjects/41574_2018_Article_BFnrendo2017173_Fig1_HTML.jpg)
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus | Nature Reviews Endocrinology
![Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41423-020-00579-3/MediaObjects/41423_2020_579_Fig1_HTML.png)
Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology
![Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease - Journal of Hepatology Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/db39f1e6-48bf-4e98-8dcb-8ca55a62a6ec/fx1_lrg.jpg)
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease - Journal of Hepatology
![Pathophysiology of liver fibrosis. After chronic liver injury, necrotic... | Download Scientific Diagram Pathophysiology of liver fibrosis. After chronic liver injury, necrotic... | Download Scientific Diagram](https://www.researchgate.net/profile/Kn-Shashidhar/publication/320239308/figure/fig3/AS:667675164422148@1536197572152/Pathophysiology-of-liver-fibrosis-After-chronic-liver-injury-necrotic-or-apoptotic_Q640.jpg)
Pathophysiology of liver fibrosis. After chronic liver injury, necrotic... | Download Scientific Diagram
![Acute-on-chronic liver failure: terminology, mechanisms and management | Nature Reviews Gastroenterology & Hepatology Acute-on-chronic liver failure: terminology, mechanisms and management | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrgastro.2015.219/MediaObjects/41575_2016_Article_BFnrgastro2015219_Fig1_HTML.jpg)
Acute-on-chronic liver failure: terminology, mechanisms and management | Nature Reviews Gastroenterology & Hepatology
![Nature Reviews Gastroenterology & Hepatology on Twitter: "#TrendingNow @DrLoomba and @ebtapper review the #elastographic assessment of liver fibrosis in #NAFLD and discuss the clinical position of specific techniques £ https://t.co/DSXUwHsBD6… https ... Nature Reviews Gastroenterology & Hepatology on Twitter: "#TrendingNow @DrLoomba and @ebtapper review the #elastographic assessment of liver fibrosis in #NAFLD and discuss the clinical position of specific techniques £ https://t.co/DSXUwHsBD6… https ...](https://pbs.twimg.com/media/DW9WUdiX0AAv5fF.jpg)
Nature Reviews Gastroenterology & Hepatology on Twitter: "#TrendingNow @DrLoomba and @ebtapper review the #elastographic assessment of liver fibrosis in #NAFLD and discuss the clinical position of specific techniques £ https://t.co/DSXUwHsBD6… https ...
![Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis - Gastroenterology Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2bf4f422-bf16-49b9-852b-96dc4318473b/gr1.jpg)
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis - Gastroenterology
![What's new in NAFLD pathogenesis, biomarkers and treatment?,Nature Reviews Gastroenterology & Hepatology - X-MOL What's new in NAFLD pathogenesis, biomarkers and treatment?,Nature Reviews Gastroenterology & Hepatology - X-MOL](https://xpic.x-mol.com/20191119%2F10.1038_s41575-019-0239-2.jpg)
What's new in NAFLD pathogenesis, biomarkers and treatment?,Nature Reviews Gastroenterology & Hepatology - X-MOL
![Liver fibrosis: Pathophysiology and clinical implications - Berumen - 2021 - WIREs Mechanisms of Disease - Wiley Online Library Liver fibrosis: Pathophysiology and clinical implications - Berumen - 2021 - WIREs Mechanisms of Disease - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/09863cb3-2251-4cce-9094-1c6f3114cc92/wsbm1499-toc-0001-m.jpg)
Liver fibrosis: Pathophysiology and clinical implications - Berumen - 2021 - WIREs Mechanisms of Disease - Wiley Online Library
![MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease in: European Journal of Endocrinology Volume 183 Issue 3 (2020) MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease in: European Journal of Endocrinology Volume 183 Issue 3 (2020)](https://eje.bioscientifica.com/view/journals/eje/183/3/images/EJE-20-0065fig2.jpeg)
MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease in: European Journal of Endocrinology Volume 183 Issue 3 (2020)
![Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease | Nature Reviews Nephrology Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease | Nature Reviews Nephrology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrneph.2017.16/MediaObjects/41581_2017_Article_BFnrneph201716_Fig1_HTML.jpg)
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease | Nature Reviews Nephrology
![Liver fibrosis and repair: immune regulation of wound healing in a solid organ | Nature Reviews Immunology Liver fibrosis and repair: immune regulation of wound healing in a solid organ | Nature Reviews Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnri3623/MediaObjects/41577_2014_Article_BFnri3623_Fig1_HTML.jpg)